Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetyl coenzyme A (Acetyl-CoA) is a central metabolite in cellular metabolism, comprised of an acetyl group covalently attached to coenzyme A via a high-energy thioester bond[1][3]. Acetyl-CoA is generated from the breakdown of carbohydrates, fatty acids, and some amino acids, and acts as a key substrate for entry into the citric acid cycle, where its acetyl group is oxidized for ATP production[1][2][4][6]. It also serves as the essential precursor for the biosynthesis of fatty acids, cholesterol, steroid hormones, and ketone bodies, as well as a donor for acetylation reactions including histone modification, influencing gene expression[4][8][2][6]. Acetyl-CoA levels and localization regulate a broad array of cellular processes by controlling energy metabolism and post-translational modifications[4][8]. While not itself a drug target (it is a metabolite, not an enzyme/protein/receptor/transporter), the metabolic enzymes that produce or utilize acetyl-CoA can be targets of drugs and therapeutic intervention in metabolic disease and cancer[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetyl coenzyme A (Acetyl-CoA).